Skip to content

7-day free trial with a card.

Plans

Why is $INTS stock down today?

Intensity Therapeutics, Inc. Common stock · Biological Products, (No Diagnostic Substances)

Why is $INTS down today?

The likely driver

Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
SEC filing · Nov 5
Price
$2.43
Friday session
-0.8%
After hours
-2.0%
Scanner alerts Friday
3
Flagged in 30 days
4
Market cap
$8M
Prev close
$2.48
Avg volume
23K

Catch the next move like INTS before the open

Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Nothing has triggered on INTS yet in this session. Our scanner has flagged it 4 times in the last 30 days , most recently on November 20 for big percentage moves, unusual volume, which is why this page is here. See the full INTS page for the chart and the alert history.

Earlier scanner activity on INTS

  • Nov 20Unusual volume (RVOL) alert
  • Nov 20Big % mover alert
  • Nov 20Unusual volume (RVOL) alert
  • Nov 19Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $INTS alerts the moment volume spikes

Our scanner flagged $INTS 4 times in the last 30 days. Create a free account to track $INTS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.